RISK OF INVOLVEMENT OF SENTINEL LYMPH NODES IN CERVICAL CANCER STAGE IA1 WITH LYMPHOVASCULAR SPACE INVASION AND AND IA2

被引：0
|
作者：
Vetrovska, M. [1 ]
Pichlik, T. [1 ]
Rob, L. [1 ]
Robova, H. [1 ]
Halaska, M. [1 ]
Drozenova, J. [2 ]
Hruda, M. [1 ]
Drochytek, V. [1 ]
机构：
[1] Charles Univ Prague, Fac Hosp Kralovske Vinohrady, Dept Gynecol & Obstet, Fac Med 3, Prague, Czech Republic
[2] Charles Univ Prague, Fac Hosp Kralovske Vinohrady, Dept Pathol, Fac Med 3, Prague, Czech Republic
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.487
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP428
引用
收藏
页码：A278 / A278
页数：1
相关论文
共 50 条
  • [31] LYMPHOVASCULAR SPACE INVASION DETERMINES THE PROGNOSIS OF STAGE IA ENDOMETRIOID ENDOMETRIAL CANCERS.
    Karalok, A.
    Ureyen, I.
    Tasci, T.
    Turkmen, O.
    Narin, M.
    Kimyon, G.
    Akyol, A.
    Aktas, Y.
    Ocalan, R.
    Tulunay, G.
    Turan, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 247 - 248
  • [32] An evaluation of 721 women with Stage IA1 cervical cancer: is conservative surgical approach safe?
    Zhu, J.
    Wu, X.
    Liu, X.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (03) : 457 - 462
  • [33] Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
    Covens, Allan
    Huang, Helen Q.
    Monk, Bradley J.
    Kim, Yong-Beom
    Kim, Moon-Hong
    Disilvestro, Paul
    Vicus, Danielle
    Holman, Laura L.
    Fleury, Almee
    Pearson, J. Matthew
    Thawani, Nitika
    Shahin, Mark S.
    Leal, Jayanthi S.
    Robertson, Sharon E.
    Warshal, David
    Backes, Floor
    Feltmate, Colleen
    Dewdney, Summer
    Leitao, Mario M.
    Wilkinson-Ryan, Ivy
    Elsayed, Ahmed G.
    Carter, Jeanne
    GYNECOLOGIC ONCOLOGY, 2025, 195 : 59 - 65
  • [34] Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer
    Xiaoyu Wang
    Yalan Bi
    Huanwen Wu
    Ming Wu
    Lei Li
    Scientific Reports, 10
  • [35] Ethnic disparity in the use of definite surgical treatment for stage IA2/IB1 cervical cancer
    Nasioudis, D.
    Chapman-Davis, E.
    Frey, M. K.
    Caputo, T. A.
    Holcomb, K. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 132 - 132
  • [36] CLINICAL AND PATHOLOGICAL FACTORS ASSOCIATED WITH RESIDUAL DISEASE IN HYSTERECTOMY AFTER CONIZATION FOR MICROINVASIVE CERVICAL CANCER (STAGE IA1AND IA2) TREATMENT
    Hartman, C. A.
    Andrade L A, L.
    Teixeira, J. C.
    Rangel Neto, O.
    Machado, H. D. C.
    Braganca Bastos, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 766 - 766
  • [37] Is a second operation in the treatment of cervical cancer FIGO IA1 essential?
    Polterauer, S.
    Hofstetter, G.
    Concin, N.
    Grimm, C.
    Reinthaller, A.
    Hefler, L.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 503 - 503
  • [38] Sentinel lymph nodes in early stage cervical cancer
    Hauspy, J.
    Beiner, M.
    Harley, I.
    Ehrlich, L.
    Rasty, G.
    Covens, A.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 285 - 290
  • [39] Sentinel lymph nodes in early stage cervical cancer
    Hauspy, Jan
    Covens, Al
    GYNECOLOGIC ONCOLOGY, 2008, 108 (01) : 256 - 257
  • [40] Lymph node metastases and prognosis in patients with stage IA(2) cervical cancer
    Buckley, SL
    Tritz, DM
    VanLe, L
    Higgins, R
    Sevin, BU
    Ueland, FR
    DePriest, PD
    Gallion, HH
    Bailey, CL
    Kryscio, RJ
    Fowler, W
    Averette, H
    Vannagell, JR
    GYNECOLOGIC ONCOLOGY, 1996, 63 (01) : 4 - 9
12345